This invention belongs to the field of pharmaceutical chemistry and relates to new diazenedicarboxamides as inhibitors of D-alanine:D-alanine ligaze (Ddl), to procedures for their preparation and pharmaceutical preparations containing the same. Compounds of general formula I:
and the pharmaceutically acceptable salts are described. The appropriate substituents are clearly presented in the body of the text and in claims.
本发明属于药物
化学领域,涉及作为
D-丙氨酸:
D-丙氨酸连接酶(Ddl)
抑制剂的新重氮二 羧酰胺、其制备程序和含有这些化合物的药物制剂。通式 I 的化合物:
及其药学上可接受的盐类。适当的取代基在正文和权利要求中均有明确表述。